Women May Not Recognize Non-Lump Symptoms of Breast Cancer
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 3, 2023 -- Fewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State University Comprehensive Cancer Center: The James (OSUCCC-James).
The survey was conducted online (974 participants) and via telephone (30 participants) from Sept. 22 to 24, 2023. Results showed that one-third of women say they are confused about recommendations for breast cancer screenings, particularly those under age 30 (44 percent). Furthermore, just 31 percent of participants recognized a retracted, inverted, or downward-pointing nipple as a symptom of breast cancer, and just 39 percent recognized breast puckering as a symptom. Similarly, fewer than half of participants were aware of loss that breast feeling (41 percent) and pitting/thickening of the breast skin (45 percent) could be symptoms. Just half recognized nipple discharge (51 percent) as a concern worthy of medical attention.
"Screening mammography is our No. 1 defense in detecting and addressing breast cancers at their earliest, most treatable stages, but it is also very important for people to be familiar with the look and feel of their own breast tissue so that sometimes subtle changes can be evaluated quickly to give us the best chance at early detection," Ashley Pariser, M.D., director of breast cancer survivorship services at the OSUCCC-James, said in a statement.
Source: HealthDay
Posted : 2023-11-04 08:36
Read more
- Health Span-Lifespan Gaps Widening Globally
- FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara
- FDA Approves Tryngolza (olezarsen) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome
- FDA Grants Revascor (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
- Maintain Muscle as You Age to Keep Brain Sharp
- FDA Approves Ryoncil (remestemcel-L-rknd) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft Versus Host Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions